Literature DB >> 21390545

Post-proteasomal and proteasome-independent generation of MHC class I ligands.

Peter van Endert1.   

Abstract

Peptide ligands presented by MHC class I molecules are produced by intracellular proteolysis, which often involves multiple steps. Initial antigen degradation seems to rely almost invariably on the proteasome, although tripeptidyl peptidase II (TPP II) and insulin-degrading enzyme (IDE) may be able to substitute for the proteasome in rare cases. Recent evidence suggests that the net effect of cytosolic aminopeptidases is destruction of potential class I ligands, although a positive role in selected cases has been documented. This may apply particularly to the trimming of long precursors by TPP II. In contrast, trimming of ligand precursors in the endoplasmic reticulum is essential for the generation of suitable peptides and has a substantial impact on the repertoire of ligands presented. Trimming by the ER aminopeptidase (ERAP) enzymes most likely acts on free precursors and is adapted to the needs of class I molecules by way of a molecular ruler mechanism. Trimming by ERAP enzymes also occurs for cross-presented ligands, which can alternatively be processed in a special endosomal compartment by insulin-regulated aminopeptidase.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21390545     DOI: 10.1007/s00018-011-0662-1

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.261


  120 in total

1.  A major role for TPPII in trimming proteasomal degradation products for MHC class I antigen presentation.

Authors:  Eric Reits; Joost Neijssen; Carla Herberts; Willemien Benckhuijsen; Lennert Janssen; Jan Wouter Drijfhout; Jacques Neefjes
Journal:  Immunity       Date:  2004-04       Impact factor: 31.745

Review 2.  Cross-talk between the endocytic pathway and the endoplasmic reticulum in cross-presentation by MHC class I molecules.

Authors:  Ngozi Monu; E Sergio Trombetta
Journal:  Curr Opin Immunol       Date:  2006-12-06       Impact factor: 7.486

Review 3.  Traffic of proteins and peptides across membranes for immunosurveillance by CD8(+) T lymphocytes: a topological challenge.

Authors:  Carolina Johnstone; Margarita Del Val
Journal:  Traffic       Date:  2007-09-06       Impact factor: 6.215

4.  Insulin-regulated aminopeptidase marks an antigen-stimulated recycling compartment in mast cells.

Authors:  Haini Liao; Susanna R Keller; J David Castle
Journal:  Traffic       Date:  2006-02       Impact factor: 6.215

5.  Antigen processing by nardilysin and thimet oligopeptidase generates cytotoxic T cell epitopes.

Authors:  Jan H Kessler; Selina Khan; Ulrike Seifert; Sylvie Le Gall; K Martin Chow; Annette Paschen; Sandra A Bres-Vloemans; Arnoud de Ru; Nadine van Montfoort; Kees L M C Franken; Willemien E Benckhuijsen; Jill M Brooks; Thorbald van Hall; Kallol Ray; Arend Mulder; Ilias I N Doxiadis; Paul F van Swieten; Hermen S Overkleeft; Annik Prat; Birgitta Tomkinson; Jacques Neefjes; Peter M Kloetzel; David W Rodgers; Louis B Hersh; Jan W Drijfhout; Peter A van Veelen; Ferry Ossendorp; Cornelis J M Melief
Journal:  Nat Immunol       Date:  2010-12-12       Impact factor: 25.606

6.  Puromycin-sensitive aminopeptidase is the major peptidase responsible for digesting polyglutamine sequences released by proteasomes during protein degradation.

Authors:  N Bhutani; P Venkatraman; A L Goldberg
Journal:  EMBO J       Date:  2007-02-22       Impact factor: 11.598

7.  Reduced activity of the hypertension-associated Lys528Arg mutant of human adipocyte-derived leucine aminopeptidase (A-LAP)/ER-aminopeptidase-1.

Authors:  Yoshikuni Goto; Akira Hattori; Yasuhiro Ishii; Masafumi Tsujimoto
Journal:  FEBS Lett       Date:  2006-02-24       Impact factor: 4.124

8.  Analysis of the role of bleomycin hydrolase in antigen presentation and the generation of CD8 T cell responses.

Authors:  Charles F Towne; Ian A York; Levi B Watkin; John S Lazo; Kenneth L Rock
Journal:  J Immunol       Date:  2007-06-01       Impact factor: 5.422

9.  Structural basis for antigenic peptide precursor processing by the endoplasmic reticulum aminopeptidase ERAP1.

Authors:  Tina T Nguyen; Shih-Chung Chang; Irini Evnouchidou; Ian A York; Christos Zikos; Kenneth L Rock; Alfred L Goldberg; Efstratios Stratikos; Lawrence J Stern
Journal:  Nat Struct Mol Biol       Date:  2011-04-10       Impact factor: 15.369

10.  Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci.

Authors:  John D Reveille; Anne-Marie Sims; Patrick Danoy; David M Evans; Paul Leo; Jennifer J Pointon; Rui Jin; Xiaodong Zhou; Linda A Bradbury; Louise H Appleton; John C Davis; Laura Diekman; Tracey Doan; Alison Dowling; Ran Duan; Emma L Duncan; Claire Farrar; Johanna Hadler; David Harvey; Tugce Karaderi; Rebecca Mogg; Emma Pomeroy; Karena Pryce; Jacqueline Taylor; Laurie Savage; Panos Deloukas; Vasudev Kumanduri; Leena Peltonen; Sue M Ring; Pamela Whittaker; Evgeny Glazov; Gethin P Thomas; Walter P Maksymowych; Robert D Inman; Michael M Ward; Millicent A Stone; Michael H Weisman; B Paul Wordsworth; Matthew A Brown
Journal:  Nat Genet       Date:  2010-01-10       Impact factor: 38.330

View more
  30 in total

1.  Predictions versus high-throughput experiments in T-cell epitope discovery: competition or synergy?

Authors:  Claus Lundegaard; Ole Lund; Morten Nielsen
Journal:  Expert Rev Vaccines       Date:  2012-01       Impact factor: 5.217

2.  Major histocompatibility complex class i and tumour immuno-evasion: how to fool T cells and natural killer cells at one time.

Authors:  D Fruci; M Benevolo; L Cifaldi; S Lorenzi; E Lo Monaco; E Tremante; P Giacomini
Journal:  Curr Oncol       Date:  2012-02       Impact factor: 3.677

3.  Distinct Escape Pathway by Hepatitis C Virus Genotype 1a from a Dominant CD8+ T Cell Response by Selection of Altered Epitope Processing.

Authors:  Andreas Walker; Kathrin Skibbe; Eike Steinmann; Stephanie Pfaender; Thomas Kuntzen; Dominik A Megger; Svenja Groten; Barbara Sitek; Georg M Lauer; Arthur Y Kim; Thomas Pietschmann; Todd M Allen; Joerg Timm
Journal:  J Virol       Date:  2015-10-07       Impact factor: 5.103

Review 4.  Generation of MHC class I ligands in the secretory and vesicular pathways.

Authors:  Margarita Del Val; Salvador Iborra; Manuel Ramos; Silvia Lázaro
Journal:  Cell Mol Life Sci       Date:  2011-03-09       Impact factor: 9.261

Review 5.  Providing ligands for MHC class I molecules.

Authors:  Peter van Endert
Journal:  Cell Mol Life Sci       Date:  2011-03-02       Impact factor: 9.261

6.  Allele-dependent processing pathways generate the endogenous human leukocyte antigen (HLA) class I peptide repertoire in transporters associated with antigen processing (TAP)-deficient cells.

Authors:  Elena Lorente; Ruth García; Daniel López
Journal:  J Biol Chem       Date:  2011-09-13       Impact factor: 5.157

7.  The amino terminus extension in the long dipeptidyl peptidase 9 isoform contains a nuclear localization signal targeting the active peptidase to the nucleus.

Authors:  Daniela Justa-Schuch; Ulrike Möller; Ruth Geiss-Friedlander
Journal:  Cell Mol Life Sci       Date:  2014-02-23       Impact factor: 9.261

8.  The effect of proteasome inhibition on the generation of the human leukocyte antigen (HLA) peptidome.

Authors:  Elena Milner; Lilach Gutter-Kapon; Michal Bassani-Strenberg; Eilon Barnea; Ilan Beer; Arie Admon
Journal:  Mol Cell Proteomics       Date:  2013-03-28       Impact factor: 5.911

9.  Inhibition of the Deubiquitinase Usp14 Diminishes Direct MHC Class I Antigen Presentation.

Authors:  Amy L Palmer; Annemieke de Jong; Yves Leestemaker; Paul P Geurink; Ruud H Wijdeven; Huib Ovaa; Brian P Dolan
Journal:  J Immunol       Date:  2017-12-27       Impact factor: 5.422

10.  ERAP1 functions override the intrinsic selection of specific antigens as immunodominant peptides, thereby altering the potency of antigen-specific cytolytic and effector memory T-cell responses.

Authors:  David P W Rastall; Yasser A Aldhamen; Sergey S Seregin; Sarah Godbehere; Andrea Amalfitano
Journal:  Int Immunol       Date:  2014-08-02       Impact factor: 4.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.